Source: International Congress 2016 – Features and impact of comorbidities in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Elene Sherozia (Tbilisi, Georgia), Elene Sherozia, Liza Peirkishvili, Lali Nikoleishvili, Tamar Kakhniashvili. Metabolic regulation during the co-existence of COPD and DM type2. Eur Respir J 2016; 48: Suppl. 60, 639

Member's Comments

No comment yet.

Related content which might interest you: Insulin resistance, lung function and exacerbation rate in chronic obstructive lung disease Source: International Congress 2015 – Monitoring airway diseases with lung function tests Year: 2015 Inflammatory markers and COPD phenotypes as predictors of COPD exacerbations Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Metabolic syndrome in patients with COPD and their association with systemic inflammation Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Irisin is associated with severe exacerbations of COPD independently of lung function, comorbidities and exercise capacity Source: International Congress 2015 – Notable abstracts in COPD: variety Year: 2015 Metabolic syndrome in patients with COPD Source: International Congress 2014 – Clinical presentations Year: 2014 Predictor parameters for exercise intolerance in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 Endothelial dysfunction and systemic inflammation in different COPD phenotypes Source: International Congress 2014 – COPD physiopathology Year: 2014 Cardiovascular comorbidities prevails in the early stages of COPD irrespective of predominant airway or emphysema phenotype Source: Annual Congress 2013 –COPD treatment Year: 2013 Association between inhaled corticosteroid use in COPD and incidence or worsening of type2 diabetes Source: International Congress 2014 – Markers Year: 2014 COPD exacerbation: Influence of severity and type of systemic inflammation on the hospitalizations rate Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Biomarkers in COPD exacerbation, the role of adiponectin Source: International Congress 2014 – Predictors Year: 2014 Features of systemic inflammation in patients with stable COPD Source: International Congress 2014 – COPD: points to ponder Year: 2014 Determinants of severity of dyspnea in COPD Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Prevalence of small airway dysfunction among GOLD stages in COPD patients Source: International Congress 2016 – Functional assessment of the airways Year: 2016 Exercise related desaturation in patients with COPD – Another step towards phenotyping the disease Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013 Lung function in the patients with COPD and with the combination COPD and grownup's diabetes Source: Eur Respir J 2003; 22: Suppl. 45, 538s Year: 2003 Role of comorbidities on mortality in patients hospitalized for COPD exacerbations Source: International Congress 2014 – The assessment of comorbidities Year: 2014 COPD: Influence of patients’ nutritive status on the exacerbations rate Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Factors associated with cognitive dysfunction in COPD patients hospitalised with exacerbations Source: International Congress 2014 – COPD markers Year: 2014 Impact of hyperglycaemia and comorbid diabetes mellitus on short and long-term outcome after COPD exacerbation Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013